Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1979 Dec;38(6):535–543. doi: 10.1136/ard.38.6.535

In-vitro reactions of lymphocytes in rheumatoid arthritis and other rheumatic diseases.

K Froebel, R D Sturrock, P Reynolds, A Grennan, A Roxburgh, R N MacSween
PMCID: PMC1000415  PMID: 539845

Abstract

Various lymphocyte functions and the percentage of different subpopulations have been measured in groups of patients with seropositive rheumatoid arthritis, seronegative ankylosing spondylitis, and psoriatic arthritis, Sjögren's syndrome, sicca complex, and in normal controls. Several abnormal results were found--in the responses to mitogens, in the antibody-dependent cytotoxic test, and in the percentages of EA rosettes (antibody sensitised chick red cells test) and surface immunoglobulin-bearing cells. In the light of these findings cytotoxicity and lymphocyte subpopulations were measured in further groups of rheumatoid arthritis patients in whom the disease was at different stages. The results showed that the changes in cytotoxic potential occurred in patients with active arthritis. Correlation tests showed significant positive associations between the percentage of SE rosette-forming cells (sheep red cells test) and the mitogenic responses to phytohaemagglutinin and concanavalin A, and between the percentage of EA rosette-forming cells and the levels of antibody-dependent cytotoxicity. The results are discussed in the light of our understanding of cellular subpopulations in the immune system.

Full text

PDF
535

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison A. C., Denman A. M., Barnes R. D. Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet. 1971 Jul 17;2(7716):135–140. doi: 10.1016/s0140-6736(71)92306-3. [DOI] [PubMed] [Google Scholar]
  2. BLOCH K. J., BUCHANAN W. W., WOHL M. J., BUNIM J. J. SJOEGREN'S SYNDROME. A CLINICAL, PATHOLOGICAL, AND SEROLOGICAL STUDY OF SIXTY-TWO CASES. Medicine (Baltimore) 1965 May;44:187–231. [PubMed] [Google Scholar]
  3. Barnett I. G., MacLennan I. C. Inhibitory effect of rheumatoid sera on cell damage by lymphocytes. Ann Rheum Dis. 1972 Sep;31(5):425–425. doi: 10.1136/ard.31.5.425-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brenner A. I., Scheinberg M. A., Cathcart E. S. Surface characteristics of synovial fluid and peripheral blood lymphocytes in inflammatory arthritis. Arthritis Rheum. 1975 Jul-Aug;18(4):297–303. doi: 10.1002/art.1780180402. [DOI] [PubMed] [Google Scholar]
  5. Campbell A. C., Hersey P., MacLennan I. C., Kay H. E., Pike M. C. Immunosuppressive consequences of radiotherapy and chemotherapy in patients with acute lymphoblastic leukaemia. Br Med J. 1973 May 19;2(5863):385–388. doi: 10.1136/bmj.2.5863.385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association. Ann Rheum Dis. 1959 Mar;18(1):49–53. [PMC free article] [PubMed] [Google Scholar]
  7. De Bracco M. M., Isturiz M. A., Manni J. A. Cell-mediated cytotoxicity. Characterization of the effector cells. Immunology. 1976 Mar;30(3):325–333. [PMC free article] [PubMed] [Google Scholar]
  8. Diaz-Jouanen E., Bankhurst A. D., Williams R. C., Jr Antibody-mediated lymphocytotoxicity in rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum. 1976 Mar-Apr;19(2):133–141. doi: 10.1002/art.1780190202. [DOI] [PubMed] [Google Scholar]
  9. Dutton R. W. Suppressor T cells. Transplant Rev. 1975;26:39–55. doi: 10.1111/j.1600-065x.1975.tb00174.x. [DOI] [PubMed] [Google Scholar]
  10. Greaves M., Janossy G., Doenhoff M. Selective triggering of human T and B lymphocytes in vitro by polyclonal mitogens. J Exp Med. 1974 Jul 1;140(1):1–18. doi: 10.1084/jem.140.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hersey P., Edwards A., Edwards J. Characterization of mononuclear effector cells in human blood. Clin Exp Immunol. 1976 Jan;23(1):104–113. [PMC free article] [PubMed] [Google Scholar]
  12. Hubert C., Delespesse G., Govaerts A. Concanavalin A-activated suppressor cells in normal human peripheral blood lymphocytes. Clin Exp Immunol. 1976 Oct;26(1):95–98. [PMC free article] [PubMed] [Google Scholar]
  13. Hurd E. R., Giuliano V. J. The effect of cyclophosphamide on B and T lymphocytes in patients with connective tissue diseases. Arthritis Rheum. 1975 Jan-Feb;18(1):67–75. doi: 10.1002/art.1780180113. [DOI] [PubMed] [Google Scholar]
  14. Isturiz M. A., De Bracco M. M., Pizzi A. M., Manni J. A. Antibody-dependent cell-mediated cytotoxicity in rheumatoid arthritis. Effect of rheumatoid serum fractions on normal lymphocytes. Arthritis Rheum. 1976 Jul-Aug;19(4):725–730. doi: 10.1002/1529-0131(197607/08)19:4<725::aid-art1780190411>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  15. Kovithavongs T., Rice G., Thong K. L., Dossetor J. B. Effector cell activity in antibody mediated cell dependent immune lysis. II. Evidence for different populations of effector cells for different targets. Cell Immunol. 1975 Jul;18(1):167–175. doi: 10.1016/0008-8749(75)90045-3. [DOI] [PubMed] [Google Scholar]
  16. Lance E. M., Knight S. C. Immunologic reactivity in rheumatoid arthritis. Response to mitogens. Arthritis Rheum. 1974 Sep-Oct;17(5):513–520. doi: 10.1002/art.1780170504. [DOI] [PubMed] [Google Scholar]
  17. Lockshin M. D., Eisenhauer A. C., Kohn R., Weksler M., Block S., Mushlin S. B. Cell-mediated immunity in rheumatic diseases. II. Mitogen responses in RA, SLE, and other illnesses: correlation with T- and B-lymphocyte populations. Arthritis Rheum. 1975 May-Jun;18(3):245–250. doi: 10.1002/art.1780180308. [DOI] [PubMed] [Google Scholar]
  18. MacSween R. N., Galbraith I., Thomas M. A., Watkinson G., Ludlam G. B. Phytohaemagglutinin (PHA) induced lymphocyte transformation and Toxoplasma gondii antibody studies in primary biliary cirrhosis. Evidence of impaired cell-mediated immunity. Clin Exp Immunol. 1973 Sep;15(1):35–42. [PMC free article] [PubMed] [Google Scholar]
  19. McGill P. E., Twinn I. Antibody-mediated cytotoxicity in rheumatoid arthritis. Ann Rheum Dis. 1977 Jun;36(3):268–270. doi: 10.1136/ard.36.3.268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Mellstedt H., Holm G. In vitro studies of lymphocytes from patients with plasma cell myeloma. I. Stimulation by mitogens and cytotoxic activities. Clin Exp Immunol. 1973 Nov;15(3):309–320. [PMC free article] [PubMed] [Google Scholar]
  21. Mitsuoka A., Baba M., Morikawa S. Enhancement of delayed hypersensitivity by depletion of suppressor T cells with cyclophosphamide in mice. Nature. 1976 Jul 1;262(5563):77–78. doi: 10.1038/262077a0. [DOI] [PubMed] [Google Scholar]
  22. Moll J. M., Wright V. Familial occurrence of psoriatic arthritis. Ann Rheum Dis. 1973 May;32(3):181–201. doi: 10.1136/ard.32.3.181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Panush R. S., Anthony C. R. Effects of acetylsalicylic acid on normal human peripheral blood lymphocytes. Inhibition of mitogen- and antigen-stimulated incorporation of tritiated thymidine. Clin Exp Immunol. 1976 Jan;23(1):114–125. [PMC free article] [PubMed] [Google Scholar]
  24. Park S. K., Brody J. I., Wallace H. A., Blakemore W. S. Immunosuppressive effect of surgery. Lancet. 1971 Jan 9;1(7689):53–55. doi: 10.1016/s0140-6736(71)90777-x. [DOI] [PubMed] [Google Scholar]
  25. Pearson C. M., Paulus H. E., Machleder H. I. The role of the lymphocyte and its products in the propagation of joint disease. Ann N Y Acad Sci. 1975 Jun 13;256:150–168. doi: 10.1111/j.1749-6632.1975.tb36044.x. [DOI] [PubMed] [Google Scholar]
  26. Rawson A. J., Huang T. C. Lymphocyte populations in rheumatoid arthritis. Arthritis Rheum. 1976 Jul-Aug;19(4):720–724. doi: 10.1002/1529-0131(197607/08)19:4<720::aid-art1780190410>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  27. Sanderson C. J., Taylor G. A. Antibody-dependent cell-mediated cytotoxicity in the rat. The role of macrophages. Immunology. 1976 Jan;30(1):117–121. [PMC free article] [PubMed] [Google Scholar]
  28. Sandilands G., Gray K., Cooney A., Froebel K., Anderson J. R. Human lymphocyte sub-populations and K cells. Int Arch Allergy Appl Immunol. 1976;50(4):416–426. doi: 10.1159/000231531. [DOI] [PubMed] [Google Scholar]
  29. Scheinberg M. A., Cathcart E. S. Antibody-dependent direct cytotoxicity of human lymphocytes. II. Studies on peripheral blood lymphocytes, synovial fluid cells and sera from patients with rheumatoid arthritis. Clin Exp Immunol. 1976 May;24(2):323–327. [PMC free article] [PubMed] [Google Scholar]
  30. Scornik J. C., Cosenza H., Lee W., Köhler H., Rowley D. A. Antibody-dependent cell-mediated cytotoxicity. I. Differentiation from antibody-independent cytotoxicity by "normal" IgG. J Immunol. 1974 Nov;113(5):1510–1518. [PubMed] [Google Scholar]
  31. Sheldon P. J., Papamichail M., Holborow E. J. Studies on synovial fluid lymphocytes in rheumatoid arthritis. Ann Rheum Dis. 1974 Nov;33(6):509–514. doi: 10.1136/ard.33.6.509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Singh J., Elson C. J., Taylor R. B. Enrichment in B cells after separation of lymphocytes from peripheral blood. J Immunol Methods. 1974 Jul;5(2):111–119. doi: 10.1016/0022-1759(74)90001-5. [DOI] [PubMed] [Google Scholar]
  33. Strong J. S., Bartholomew B. A., Smyth C. J. Immunoresponsiveness of patients with rheumatoid arthritis receiving cyclophosphamide or gold salts. Ann Rheum Dis. 1973 May;32(3):233–237. doi: 10.1136/ard.32.3.233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Talal N., Sylvester R. A., Daniels T. E., Greenspan J. S., Williams R. C., Jr T and B lymphocytes in peripheral blood and tissue lesions in Sjögren's syndrome. J Clin Invest. 1974 Jan;53(1):180–189. doi: 10.1172/JCI107536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Tse H. Y., Dutton R. W. Separation of helper and suppressor T lymphocytes. II. Ly phenotypes and lack of DNA synthesis requirement for the generation of concanavalin A helper and suppressor cells. J Exp Med. 1977 Sep 1;146(3):747–758. doi: 10.1084/jem.146.3.747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Whaley K., Williamson J., Chisholm D. M., Webb J., Mason D. K., Buchanan W. W. Sjogren's syndrome. I. Sicca components. Q J Med. 1973 Apr;42(166):279–304. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES